Ascendis Pharma A/S (ASND)
225.00
-5.21
(-2.26%)
USD |
NASDAQ |
Feb 20, 16:00
225.74
+0.74
(+0.33%)
After-Hours: 20:00
Ascendis Pharma Total Assets (Quarterly) : 1.530B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novo Nordisk A/S | 85.37B |
| Evaxion AS | 25.24M |
| DBV Technologies SA | 110.50M |
| Cellectis SA | 343.04M |
| Biodexa Pharmaceuticals Plc | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.721B |
| Shareholders Equity (Quarterly) | -191.23M |
| Debt to Equity Ratio | -5.354 |
| Current Ratio | 1.037 |
| Net Debt Paydown Yield | -0.22% |